Published in
American Association for the Advancement of Science, Science Translational Medicine, 602(13), 2021
DOI: 10.1126/scitranslmed.aba4627
Links
Tools
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer
Journal article published in 2021 by
Stelios Chrysostomou 
,
Rajat Roy ,
Filippo Prischi ,
Lucksamon Thamlikitkul ,
Kathryn L. Chapman,
Uwais Mufti ,
Robert Peach ,
Laifeng Ding ,
David Hancock ,
Christopher Moore ,
Miriam Molina-Arcas ,
Francesco Mauri,
David J. Pinato ,
Joel M. Abrahams,
Silvia Ottaviani
and other authors.
,
Rajat Roy ,
Filippo Prischi ,
Lucksamon Thamlikitkul ,
Kathryn L. Chapman,
Uwais Mufti ,
Robert Peach ,
Laifeng Ding ,
David Hancock ,
Christopher Moore ,
Miriam Molina-Arcas ,
Francesco Mauri,
David J. Pinato ,
Joel M. Abrahams,
Silvia Ottaviani
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
RSK4 promotes invasiveness and drug resistance in lung and bladder cancer and inhibition of this kinase shows therapeutic potential.